Research Article

Interleukin-16 Gene Polymorphisms Are Considerable Host Genetic Factors for Patients’ Susceptibility to Chronic Hepatitis B Infection

Table 3

Allele and genotype frequency of three SNPs among chronic HBV patients versus HBV clearance subjects.

SNPVariableHBV clearance ( = 105) (%)HBV patient ( = 245) (%) Adjusted OR (95% CI),

rs4072111Genotypes
 CC86 (81.9)181 (73.9)1.00 (reference)
 CT17 (16.2)58 (23.7)0.577 (0.307–1.082), 0.086
 TT2 (1.9)6 (2.4)0.814 (0.142–4.672), 0.817
Alleles
 C189 (89.6)420 (85.7)1.00 (reference)
 T21 (10.4)70 (14.3)0.651 (0.378–1.121), 0.122

rs11556218Genotypes
 TT16 (15.2)43 (17.6)1.00 (reference)
 TG63 (60)147 (60)1.118 (0.567–2.203), 0.748
 GG26 (24.8)55 (22.4)1.298 (0.594–2.836), 0.513
Alleles
 T95 (45.2)233 (47.6)1.00 (reference)
 G115 (54.8)257 (52.4)1.109 (0.788–1.561), 0.509

rs4778889Genotypes
 TT68 (64.8)156 (63.7)1.00 (reference)
 TC29 (27.6)84 (34.3)0.785 (0.459–1.342), 0.376
 CC8 (7.6)5 (2)3.723 (1.100–12.602), 0.035
Alleles
 T165 (78.6)396 (80.8)1.00 (reference)
 C45 (21.4)94 (19.2)1.144 (0.751–1.744), 0.531

Adjusted for confounder variables: age and gender.